3
Announcements
Trials
Browse
Landscape
Status
Terminated
1
Enrolling by invitation
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Lymphoid
1
Genitourinary
1
Conditions
Prostatic Neoplasms
1
Lymphoma, B-Cell
1
Leukemia, Myeloid, Acute
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hematologic Neoplasms
1
Interventions
enzalutamide
1
dynorphin-converting endopeptidase
1
Surveys and Questionnaires
1
Specimen Handling
1
Radiosurgery
1
Magnetic Resonance Imaging
1
Inosine Monophosphate
1
Genetic Testing
1
Genetic Counseling
1
Fluorodeoxyglucose F18
1
Brachytherapy
1
Biopsy
1
Antibiotic Prophylaxis
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Enrolling by invitation
×
Prostatic Neoplasms
×
Inosine Monophosphate
×
Clear all
NCT07474051
2026-03-16
PERSIST
AvenCell Therapeutics, Inc.
Enrolling by invitation
178 enrolled